{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:04:51Z","timestamp":1788177891156,"version":"build-2803163510"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Scientific Research,Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07916"],"award-info":[{"award-number":["19K07916"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2020,10,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>White matter lesions are frequently found in mild cognitive impairments and\nAlzheimer\u2019s disease. Matrix metalloproteinases and the tissue inhibitor of metalloproteinases are implicated\nin amyloid-\u03b2 catabolism and blood brain barrier permeability. However, it remains unclear\nwhether they are associated with white matter lesions in Alzheimer\u2019s disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study was to examine the association of matrix metalloproteinases and tissue\ninhibitor of metalloproteinases with white matter degeneration in subjects with amyloid-positive mild\ncognitive impairment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Thirty subjects with amnestic mild cognitive impairment (14 men and 16 women; mean age,\n75.6 \u00b1 5.8 years) underwent magnetic resonance imaging, <jats:sup>11<\/jats:sup>C-Pittsburgh Compound B positron emission\ntomography, and <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography. Levels of plasma matrix\nmetalloproteinases and tissue inhibitor of metalloproteinases were measured using multiplex assays. All\nsubjects had an abnormal brain amyloid burden. Subjects were divided into two groups according to the\npresence of white matter lesions using the Fazekas scale. Cognitive function testing results i.e., mean\n<jats:sup>11<\/jats:sup>C-Pittsburgh Compound B and <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose uptake, concentrations of matrix metalloproteinases\nand tissue inhibitor of metalloproteinases, and matrix metalloproteinases\/tissue inhibitor of metalloproteinases\nratios were compared between the groups. Correlation analysis was conducted to investigate\nthe association between Fazekas scale score and clinical and neuroimaging variables as well as\nconcentrations of matrix metalloproteinases and tissue inhibitor of metalloproteinases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Matrix metalloproteinases-2, -8, and -9 levels, matrix metalloproteinases-2\/ tissue inhibitor of\nmetalloproteinases-2, matrix metalloproteinases-8\/ tissue inhibitor of metalloproteinases-1, and matrix\nmetalloproteinases-9\/tissue inhibitor of metalloproteinases-1 significantly increased and tissue inhibitor\nof metalloproteinases-1 and-2 levels significantly decreased in the group with white matter lesions compared\nwith the group without white matter lesions. Matrix metalloproteinases-2, -8, and -9 levels correlated\npositively and tissue inhibitor of metalloproteinases-1 and -2 levels correlated negatively with\nFazekas scale score.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Plasma matrix metalloproteinases-2, -8, -9 and tissue inhibitor of metalloproteinases-1 and\n-2 levels are associated with white matter lesions in the mild cognitive impairment stage of Alzheimer\u2019s\ndisease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205017666200810171322","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T08:13:28Z","timestamp":1597220008000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between Matrix Metalloproteinases, Their Tissue Inhibitor and White Matter Lesions in Mild Cognitive Impairment"],"prefix":"10.2174","volume":"17","author":[{"given":"Noriyuki","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Neurology, Oita University, Faculty of Medicine, Graduate School of Medicine, Oita 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Oita University, Faculty of Medicine, Graduate School of Medicine, Oita 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasumi","family":"Etou","sequence":"additional","affiliation":[{"name":"Oita University, Faculty of Medicine, Graduate School of Medicine, Oita 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oita University, Faculty of Medicine, Graduate School of Medicine, Oita 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oita University, Faculty of Medicine, Graduate School of Medicine, Oita 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.410190306","volume":"19","author":"Brun A.","year":"1986","unstructured":"Brun A.; Englund E.; A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986,19(3),253-262","journal-title":"Ann Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"Fazekas F.","year":"1987","unstructured":"Fazekas F.; Chawluk J.B.; Alavi A.; Hurtig H.I.; Zimmerman R.A.; MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 1987,149(2),351-356","journal-title":"AJR Am J Roentgenol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/gps.1283","volume":"20","author":"Lazarus R.","year":"2005","unstructured":"Lazarus R.; Prettyman R.; Cherryman G.; White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders. Int J Geriatr Psychiatry 2005,20(3),274-279","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000345184","volume":"34","author":"Kimura N.","year":"2012","unstructured":"Kimura N.; Nakama H.; Nakamura K.; Aso Y.; Kumamoto T.; Effect of white matter lesions on brain perfusion in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 2012,34(3-4),256-261","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ageing\/25.6.443","volume":"25","author":"Amar K.","year":"1996","unstructured":"Amar K.; Bucks R.S.; Lewis T.; Scott M.; Wilcock G.K.; The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing 1996,25(6),443-448","journal-title":"Age Ageing"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archneur.1992.00530300062011","volume":"49","author":"Almkvist O.","year":"1992","unstructured":"Almkvist O.; Wahlund L.O.; Andersson-Lundman G.; Basun H.; B\u00e4ckman L.; White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992,49(6),626-632","journal-title":"Arch Neurol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clineuro.2018.02.030","volume":"168","author":"Ishibashi M.","year":"2018","unstructured":"Ishibashi M.; Kimura N.; Aso Y.; Matsubara E.; Effects of white matter lesions on brain perfusion in patients with mild cognitive impairment. Clin Neurol Neurosurg 2018,168,7-11","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000366411","volume":"39","author":"Shim Y.S.","year":"2015","unstructured":"Shim Y.S.; Yang D.W.; Roe C.M.; Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dement Geriatr Cogn Disord 2015,39(1-2),92-104","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"Wardlaw J.M.","year":"2013","unstructured":"Wardlaw J.M.; Smith E.E.; Biessels G.J.; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013,12(8),822-838","journal-title":"Lancet Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2019.09.017","volume":"85","author":"Freeze W.M.","year":"2020","unstructured":"Freeze W.M.; Jacobs H.I.L.; de Jong J.J.; White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed. Neurobiol Aging 2020,85,113-122","journal-title":"Neurobiol Aging"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"Yong V.W.","year":"2001","unstructured":"Yong V.W.; Power C.; Forsyth P.; Edwards D.R.; Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001,2(7),502-511","journal-title":"Nat Rev Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1096\/fasebj.12.12.1075","volume":"12","author":"Massova I.","year":"1998","unstructured":"Massova I.; Kotra L.P.; Fridman R.; Mobashery S.; Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J 1998,12(12),1075-1095","journal-title":"FASEB J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","volume":"68","author":"Bruno M.A.","year":"2009","unstructured":"Bruno M.A.; Mufson E.J.; Wuu J.; Cuello A.C.; Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 2009,68(12),1309-1318","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"Whelan C.D.","year":"2019","unstructured":"Whelan C.D.; Mattsson N.; Nagle M.W.; Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol Commun 2019,7(1),169","journal-title":"Acta Neuropathol Commun"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-143186","volume":"48","author":"Duits F.H.","year":"2015","unstructured":"Duits F.H.; Hernandez-Guillamon M.; Montaner J.; Matrix metalloproteinases in Alzheimer\u2019s disease and concurrent cerebral microbleeds. J Alzheimers Dis 2015,48(3),711-720","journal-title":"J Alzheimers Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-2011-101974","volume":"26","author":"Lim N.K.","year":"2011","unstructured":"Lim N.K.; Villemagne V.L.; Soon C.P.; Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer\u2019s disease. J Alzheimers Dis 2011,26(4),779-786","journal-title":"J Alzheimers Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3233\/JAD-180752","volume":"66","author":"Tuna G.","year":"2018","unstructured":"Tuna G.; Yener G.G.; Oktay G.; \u0130\u015flekel G.H.; K\u0130rkal\u0130 FG. K\u0130rkal\u0130 FG. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in plasma from patients with neurodegenerative dementia. J Alzheimers Dis 2018,66(3),1265-1273","journal-title":"J Alzheimers Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1161\/01.STR.0000244808.17972.55","volume":"37","author":"Nakaji K.","year":"2006","unstructured":"Nakaji K.; Ihara M.; Takahashi C.; Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke 2006,37(11),2816-2823","journal-title":"Stroke"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020599","volume":"6","author":"Feng S.","year":"2011","unstructured":"Feng S.; Cen J.; Huang Y.; Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One 2011,6(8)","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"Rempe R.G.","year":"2016","unstructured":"Rempe R.G.; Hartz A.M.S.; Bauer B.; Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab 2016,36(9),1481-1507","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","volume":"35","author":"Brkic M.","year":"2015","unstructured":"Brkic M.; Balusu S.; Van Wonterghem E.; Amyloid \u03b2 oligomers disrupt Blood-CSF barrier integrity by activating matrix Metalloproteinases. J Neurosci 2015,35(37),12766-12778","journal-title":"J Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000110111","volume":"6","author":"Molgaard C.A.","year":"1987","unstructured":"Molgaard C.A.; Multivariate analysis of Hachinski\u2019s Scale for discriminating senile dementia of the Alzheimer\u2019s Type from multiinfarct dementia. Neuroepidemiology 1987,6(3),153-160","journal-title":"Neuroepidemiology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"Jack C.R.","year":"2018","unstructured":"Jack C.R.; Bennett D.A.; Blennow K.; Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 2018,14(4),535-562","journal-title":"Alzheimers Dement"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204313","volume":"13","author":"Yi H.A.","year":"2018","unstructured":"Yi H.A.; Won K.S.; Chang H.W.; Kim H.W.; Association between white matter lesions and cerebral A\u03b2 burden. PLoS One 2018,13(9)","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1567205016666190805155230","volume":"16","author":"Eguchi A.","year":"2019","unstructured":"Eguchi A.; Kimura N.; Aso Y.; Relationship between the Japanese version of the Montreal cognitive assessment and PET imaging in subjects with mild cognitive impairment. Curr Alzheimer Res 2019,16(9),852-860","journal-title":"Curr Alzheimer Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"Herholz K.","year":"2002","unstructured":"Herholz K.; Salmon E.; Perani D.; Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002,17(1),302-316","journal-title":"Neuroimage"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awm336","volume":"131","author":"Jack C.R.","year":"2008","unstructured":"Jack C.R.; Lowe V.J.; Senjem M.L.; 11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment. Brain 2008,131(Pt 3),665-680","journal-title":"Brain"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1161\/STROKEAHA.115.010351","volume":"46","author":"Egashira Y.","year":"2015","unstructured":"Egashira Y.; Zhao H.; Hua Y.; Keep R.F.; Xi G.; White matter injury after subarachnoid hemorrhage: Role of blood-brain barrier disruption and matrix metalloproteinase-9. Stroke 2015,46(10),2909-2915","journal-title":"Stroke"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.002","volume":"23","author":"Corbin Z.A.","year":"2014","unstructured":"Corbin Z.A.; Rost N.S.; Lorenzano S.; White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke. J Stroke Cerebrovasc Dis 2014,23(6),1300-1306","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2018.02.012","volume":"271","author":"Palm F.","year":"2018","unstructured":"Palm F.; Pussinen P.J.; Safer A.; Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke. Atherosclerosis 2018,271,9-14","journal-title":"Atherosclerosis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jns.2014.09.012","volume":"346","author":"Tokuchi R.","year":"2014","unstructured":"Tokuchi R.; Hishikawa N.; Kurata T.; Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer\u2019s disease and reverting to normal cognition. J Neurol Sci 2014,346(1-2),288-292","journal-title":"J Neurol Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-019-0521-0","volume":"11","author":"Puzo C.","year":"2019","unstructured":"Puzo C.; Labriola C.; Sugarman M.A.; Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: A longitudinal investigation using the National Alzheimer\u2019s Coordinating Center Uniform Data Set. Alzheimers Res Ther 2019,11(1),64","journal-title":"Alzheimers Res Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnagi.2016.00027","volume":"8","author":"Liang Y.","year":"2016","unstructured":"Liang Y.; Sun X.; Xu S.; Liu Y.; Huang R.; Jia J.; Preclinical cerebral network connectivity evidence of deficits in mild white matter lesions. Front Aging Neurosci 2016,8,27","journal-title":"Front Aging Neurosci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-2011-110566","volume":"27","author":"Bjerke M.","year":"2011","unstructured":"Bjerke M.; Zetterberg H.; Edman \u00c5.; Blennow K.; Wallin A.; Andreasson U.; Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer\u2019s disease. J Alzheimers Dis 2011,27(3),665-676","journal-title":"J Alzheimers Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00018-019-03178-2","volume":"76","author":"Rivera S.","year":"2019","unstructured":"Rivera S.; Garc\u00eda-Gonz\u00e1lez L.; Khrestchatisky M.; Baranger K.; Metalloproteinases and their tissue inhibitors in Alzheimer\u2019s disease and other neurodegenerative disorders. Cell Mol Life Sci 2019,76(16),3167-3191","journal-title":"Cell Mol Life Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00004647-200107000-00008","volume":"21","author":"Ihara M.","year":"2001","unstructured":"Ihara M.; Tomimoto H.; Kinoshita M.; Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab 2001,21(7),828-834","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"Asahi M.","year":"2001","unstructured":"Asahi M.; Wang X.; Mori T.; Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001,21(19),7724-7732","journal-title":"J Neurosci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.neurobiolaging.2008.11.004","volume":"31","author":"Romero J.R.","year":"2010","unstructured":"Romero J.R.; Vasan R.S.; Beiser A.S.; Association of matrix metalloproteinases with MRI indices of brain ischemia and aging. Neurobiol Aging 2010,31(12),2128-2135","journal-title":"Neurobiol Aging"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/659282","volume":"2013","author":"Lenglet S.","year":"2013","unstructured":"Lenglet S.; Mach F.; Montecucco F.; Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm 2013,2013","journal-title":"Mediators Inflamm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","volume":"26","author":"Yin K.J.","year":"2006","unstructured":"Yin K.J.; Cirrito J.R.; Yan P.; Hu X.; Xiao Q.; Pan X.; Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 2006,26(43),10939-10948","journal-title":"J Neurosci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/S1041610207005790","volume":"20","author":"Lorenzl S.","year":"2008","unstructured":"Lorenzl S.; Buerger K.; Hampel H.; Beal M.F.; Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Int Psychogeriatr 2008,20(1),67-76","journal-title":"Int Psychogeriatr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1523\/JNEUROSCI.2462-12.2012","volume":"32","author":"Hedden T.","year":"2012","unstructured":"Hedden T.; Mormino E.C.; Amariglio R.E.; Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci 2012,32(46),16233-16242","journal-title":"J Neurosci"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184750","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184750\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T01:20:24Z","timestamp":1613697624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184750\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,10,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205017666200810171322","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}